Vivos Therapeutics (VVOS) Share-based Compensation (2020 - 2026)
Vivos Therapeutics (VVOS) reported Share-based Compensation of $151000.0 for Q1 2026, down 52.37% year-over-year from $317000.0 in Q1 2025, and up 75.58% quarter-over-quarter from $86000.0 in Q4 2025.
Vivos Therapeutics (VVOS) Share-based Compensation (2020 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has 7 years of Share-based Compensation data on file, last reported at $151000.0 in Q1 2026.
- Share-based Compensation for Q1 2026 came in at $151000.0, down 52.37% year-over-year; the trailing twelve-month figure through Mar 2026 was $637000.0 (down 91.42% YoY), and the FY2025 annual result was $700000.0, up 6263.64% from the prior year.
- Share-based Compensation advanced to $151000.0 in Q1 2026 per VVOS's latest filing, from $86000.0 in the prior quarter.
- Over five years, Share-based Compensation peaked at $7.5 million in Q2 2024 and troughed at -$689000.0 in Q4 2024.
- A 5-year average of $699647.1 and a median of $300000.0 in 2024 frame the typical range for Share-based Compensation.
- On a YoY basis, Share-based Compensation climbed as much as 1775.0% in 2024 and fell as far as 571.92% in 2024.
- A 5-year view of Share-based Compensation shows it stood at $775000.0 in 2022, then plunged by 81.16% to $146000.0 in 2023, then sank by 571.92% to -$689000.0 in 2024, then soared by 112.48% to $86000.0 in 2025, then surged by 75.58% to $151000.0 in 2026.
- Business Quant data shows VVOS's Share-based Compensation at $151000.0 in Q1 2026, $86000.0 in Q4 2025, and $100000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 87.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 94.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 35.12 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 43.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 12.90 Mn |
| 10 | Vivos Therapeutics | 7.39 Mn | 5.16 Mn | 3.06 Mn | 151,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 151,000.00 |
| Mar 31, 2026 | 151,000.00 |
| Dec 31, 2025 | 86,000.00 |
| Dec 31, 2025 | 86,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 300,000.00 |
| Jun 30, 2025 | 300,000.00 |
| Mar 31, 2025 | 317,000.00 |
| Mar 31, 2025 | 317,000.00 |
| Dec 31, 2024 | -689,000.00 |
| Dec 31, 2024 | -689,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Sep 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 7.50 Mn |
| Jun 30, 2024 | 7.50 Mn |
| Mar 31, 2024 | 293,000.00 |
| Mar 31, 2024 | 293,000.00 |
| Dec 31, 2023 | 146,000.00 |
| Dec 31, 2023 | 146,000.00 |